BSX analyst estimates
Boston Scientific (BSX) analyst ratings, the average price target and its range, and every firm's latest call.
BSX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Boston Scientific (BSX) PT Lowered to $48 at Canaccord | $48.00 |
| Oct 29, 2026 | Mizuho Securities | Boston Scientific (BSX) PT Lowered to $50 at Mizuho | $50.00 |
| Oct 29, 2026 | Leerink Partners | Boston Scientific price target lowered to $50 from $55 at Leerink | $50.00 |
| Oct 29, 2026 | BTIG | Boston Scientific price target lowered to $49 from $56 at BTIG | $49.00 |
| Oct 29, 2026 | Deutsche Bank | Boston Scientific price target lowered to $48 from $60 at Deutsche Bank | $48.00 |
| Oct 29, 2026 | RBC Capital | Boston Scientific price target lowered to $52 from $70 at RBC Capital | $52.00 |
| Oct 28, 2026 | Needham | Boston Scientific price target lowered to $48 from $57 at Needham | $48.00 |
| Oct 28, 2026 | Jefferies | Boston Scientific downgraded to Hold from Buy at Jefferies | $46.00 |
| Oct 26, 2026 | Stifel Nicolaus | Boston Scientific price target lowered to $55 from $60 at Stifel | $55.00 |
| Oct 14, 2026 | Truist Financial | Boston Scientific price target lowered to $51 from $57 at Truist | $51.00 |
| Oct 13, 2026 | Mizuho Securities | Boston Scientific price target lowered to $55 from $60 at Mizuho | $55.00 |
| Oct 6, 2026 | Barclays | Boston Scientific initiated with an Equal Weight at Barclays | $48.00 |
| Oct 3, 2026 | Bernstein | Boston Scientific price target lowered to $54 from $60 at Bernstein | $54.00 |
| Sep 23, 2026 | Wells Fargo | Boston Scientific price target lowered to $48 from $50 at Wells Fargo | $48.00 |
| Sep 21, 2026 | Oppenheimer | Boston Scientific price target lowered to $65 from $85 at Oppenheimer | $65.00 |
- 25 firms rate BSX: 18 buy, 7 hold, 0 sell.
- The average price target is $50.86 from 14 analysts, from $46.00 to $65.00.
Updated 2026-11-02 17:53 UTC